Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) Equity Average (2016 - 2025)

PAVmed has reported Equity Average over the past 5 years, most recently at $27.4 million for Q4 2025.

  • For Q4 2025, Equity Average rose 722.88% year-over-year to $27.4 million; the TTM value through Dec 2025 reached $27.4 million, up 722.88%, while the annual FY2025 figure was $9.9 million, 174.7% up from the prior year.
  • Equity Average for Q4 2025 was $27.4 million at PAVmed, down from $30.3 million in the prior quarter.
  • Over five years, Equity Average peaked at $72.1 million in Q1 2022 and troughed at -$22.3 million in Q1 2024.
  • A 5-year average of $19.9 million and a median of $21.8 million in 2021 define the central range for Equity Average.
  • Biggest five-year swings in Equity Average: plummeted 493.19% in 2024 and later surged 722.88% in 2025.
  • Year by year, Equity Average stood at $57.3 million in 2021, then tumbled by 65.56% to $19.7 million in 2022, then tumbled by 200.9% to -$19.9 million in 2023, then surged by 116.72% to $3.3 million in 2024, then surged by 722.88% to $27.4 million in 2025.
  • Business Quant data shows Equity Average for PAVM at $27.4 million in Q4 2025, $30.3 million in Q3 2025, and $33.5 million in Q2 2025.